Skip to content
Storytelling Co – Lifestyle
Author:
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
June 30, 2026
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
June 16, 2026
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
April 24, 2026
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey’s Aquanil Brand for Sensitive Skin
March 18, 2026